OT: Today we have an example of what a "HOLD "placed by the FDA can do to the PPS of a company with a drug in clinical trial. The company is Regulus Therapeutics (RGLS) even though they reportedly have in CASH over $1.70 their stock is down to $1.15.

NOTE: This is meant as an example not a BUY/SELL recomendation